Company Data
Applied Therapeutics Inc.
Ticker
APLT
Current Price
$4.41 0.68%
Market Cap
$467.0M
Price Target
Refer to Report
Volume
1.1M
52wk Range
$0.88 - $9.39
Overview
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.